Part of the fallout from the coronavirus outbreak could be drug shortages caused by active pharmaceutical ingredient manufacturing disruptions in China and other regions. Supply appears stable for now, but shortages could become an issue late in the second quarter or early third quarter if manufacturing disruptions continue longer term, Bernstein Research analyst Ronny Gal concluded in a 26 February research report.
Gal's research on the risks to the global drug supply chain caused by coronavirus was based on discussions with four...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
